Back

Socioeconomic disparity in utilization of transcatheter aortic valve replacement

2 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Diversity and specific populations in valvular heart disease Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Yonggu Lee

Hanyang University Guri Hospital, Seoul (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Demographics and clinical outcomes of flow-gradient patterns of aortic stenosis: an analysis of the CURRENT AS Registry-2.
Doctor T. Taniguchi (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Inter-ethnic heterogeneity in valvular morphology and aortopathy of a worldwide bicuspid aortic valve cohort referred for TAVR
Doctor M. Barki (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Clinical impact of transcatheter aortic valve implantation (TAVI) in frail patients: a single-center prospective study
Doctor D. Martinez Lopez (Alicante, ES)
Abstract Slides Video
Presentation thumbnail
Symptoms of Anxiety and Depression (SAD) in patients undergoing transcatheter aortic valve implantation. A multicentre Australian experience: The SAD-TAVI Study
Doctor A. Butala (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Comic-based consenting on patient-reported experience and outcome measures for transfemoral aortic valve implantation
Doctor T. Thevathasan (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Diversity and specific populations in valvular heart disease

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Session
Improving prognosis after TAVI
thumbnail
Congress Presentation
Changes in demographics, strategies, and clinical outcomes of severe aortic stenosis in the pre- and post-TAVR Era
thumbnail
Congress Presentation
Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources